…
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal processing; and AI PrecisionPulse Neural Network for the analysis of biometric signals to detect cardiovascular anomalies and personalized health recommendations, as well as Health Gauge's solutions that capture vital signs, such as blood pressure, heart rate, and pulse wave velocity. It also engages in the research and development of health and wearable technologies; and sale of licenses and consulting services related to the company's technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. is headquartered in Victoria, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
AI/ML Innovations Inc is a Canada-listed company with limited public disclosures that operates in the artificial intelligence and machine-learning sector. Long-term growth drivers for the industry include broader enterprise AI adoption, more data and cheaper cloud compute, which may benefit companies that commercialize scalable models or services. Investors may find exposure to the AI sector attractive if the company can demonstrate revenue traction and differentiation.
Material risks include limited disclosure, execution risk in commercializing products, strong competition from larger players and the likely need for additional financing.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
| Income before tax | -4.59M | -3.29M | -1.49M | -3.55M | -2.83M |
| Minority interest | -0.00M | 0.01M | 0.07M | 0.38M | -0.22M |
| Net income | -4.59M | -3.28M | -1.42M | -3.17M | -2.73M |
| Selling general administrative | 4.50M | 1.71M | 1.45M | 2.99M | 1.37M |
| Gross profit | 0.16M | 0.29M | 0.47M | 0.07M | - |
| Reconciled depreciation | 0.03M | 0.04M | 0.04M | 0.04M | 0.00M |
| Ebit | - | - | -1.35M | -3.35M | -1.60M |
| Ebitda | - | - | - | -3.44M | -2.79M |
| Operating income | -4.84M | -1.62M | -1.35M | -3.35M | -1.43M |
| Other operating expenses | - | - | - | 0.00M | 0.03M |
| Interest expense | 0.02M | 0.05M | 0.06M | 0.07M | 0.04M |
| Interest income | 0.00M | 0.00M | - | - | - |
| Net interest income | -0.03M | -0.05M | -0.06M | -0.07M | -0.04M |
| Total revenue | 0.17M | 0.60M | 0.49M | 0.07M | 0.00M |
| Total operating expenses | 5.00M | 2.22M | 1.83M | 3.42M | 1.43M |
| Cost of revenue | 0.00M | 0.31M | 0.02M | 0.00M | - |
| Total other income expense net | 0.28M | -1.62M | -0.09M | -0.13M | -1.35M |
| Net income from continuing ops | -4.59M | -3.29M | -1.49M | -3.55M | -2.83M |
| Net income applicable to common shares | - | - | -1.42M | -3.17M | -2.73M |
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
| Total assets | 3.41M | 0.33M | 1.51M | 2.04M | 3.59M |
| Intangible assets | 0.90M | - | - | - | - |
| Total liab | 0.86M | 1.54M | 1.79M | 1.55M | 1.51M |
| Total stockholder equity | 2.60M | -1.17M | -0.25M | 1.08M | 2.31M |
| Other current liab | - | - | 0.06M | 0.05M | 0.05M |
| Common stock | - | - | 25.79M | 25.28M | 23.74M |
| Capital stock | 32.04M | 27.12M | 25.79M | 25.28M | 23.74M |
| Retained earnings | -39.73M | -34.81M | -31.74M | -30.70M | -27.53M |
| Cash | 1.99M | 0.20M | 0.00M | 0.48M | 3.37M |
| Total current liabilities | 0.82M | 1.54M | 1.79M | 1.46M | 1.47M |
| Net debt | - | - | 0.16M | - | - |
| Short long term debt | 0.13M | 0.13M | 0.17M | 0.13M | 0.28M |
| Other stockholder equity | - | - | 5.70M | 6.51M | 6.09M |
| Property plant equipment | - | - | 0.04M | 0.08M | - |
| Total current assets | 2.45M | 0.33M | 0.23M | 0.90M | 3.59M |
| Long term investments | - | 0.00M | 1.24M | 1.06M | 0.00M |
| Net tangible assets | - | - | -0.25M | 1.08M | 2.31M |
| Short term investments | 0.01M | 0.02M | 0.01M | 0.05M | 0.12M |
| Net receivables | 0.01M | 0.02M | 0.12M | 0.02M | 0.03M |
| Long term debt | - | - | - | 0.04M | 0.04M |
| Inventory | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Accounts payable | 0.31M | 0.37M | 0.56M | 0.35M | 0.32M |
| Non current assets total | 0.97M | 0.00M | 1.28M | 1.14M | 0.00M |
| Capital lease obligations | 0.07M | 0.00M | 0.05M | 0.09M | 0.00M |
| Breakdown | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
| Investments | -0.00M | -0.33M | -0.21M | -1.09M | -1.09M |
| Change to liabilities | - | - | 0.36M | 0.03M | -0.00M |
| Total cashflows from investing activities | - | - | -0.21M | -1.09M | -0.01M |
| Net borrowings | -0.03M | -0.09M | -0.06M | -0.21M | 0.02M |
| Total cash from financing activities | 5.78M | 2.16M | 0.37M | 1.22M | 4.17M |
| Change to operating activities | - | - | 0.25M | -0.26M | -0.13M |
| Net income | -4.59M | -3.28M | -1.42M | -3.17M | -2.73M |
| Change in cash | 1.79M | 0.20M | -0.47M | -2.89M | 3.23M |
| Begin period cash flow | 0.20M | 0.00M | 0.48M | 3.37M | 0.14M |
| End period cash flow | 1.99M | 0.20M | 0.00M | 0.48M | 3.37M |
| Total cash from operating activities | -3.99M | -1.64M | -0.63M | -3.02M | -0.93M |
| Issuance of capital stock | 6.14M | 2.21M | 0.29M | 0.76M | 3.75M |
| Depreciation | 0.03M | 0.04M | 0.04M | 0.04M | 0.17M |
| Other cashflows from investing activities | - | - | - | -0.06M | -0.06M |
| Dividends paid | 0.00M | 0.00M | - | - | - |
| Change to inventory | 0.00M | 0.00M | 0.00M | -0.00M | -0.00M |
| Change to account receivables | - | - | -0.09M | 0.01M | 0.02M |
| Other cashflows from financing activities | - | - | -0.01M | -0.04M | -0.07M |
| Change to netincome | - | - | 0.22M | 0.34M | 1.74M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.03M |
| Change in working capital | 0.40M | -0.17M | 0.51M | -0.23M | -0.11M |
| Stock based compensation | 0.41M | 0.03M | 0.09M | 0.34M | 0.48M |
| Other non cash items | 0.03M | 0.13M | -0.01M | -3.31M | 0.19M |
| Free cash flow | -3.99M | -1.64M | -0.65M | -3.02M | -0.93M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AIML AI/ML Innovations Inc |
- -% |
0.04 | - | - | 70.85 | 35.17 | 68.77 | -3.59 |
| AIDR Rocket Doctor AI Inc |
-0.01 1.06% |
0.47 | - | - | 1671.77 | 6.46 | 59.80 | -0.39 |
| NARA Pangenomic Health Inc. |
- -% |
0.30 | - | - | - | 5.38 | - | -0.11 |
| DMED Diagnamed Holdings Corp. |
-0.01 14.29% |
0.03 | - | - | - | 10.74 | - | -1.43 |
| UDOC UniDoc Health Corp. |
0.01 11.11% |
0.05 | - | - | 10.64 | 668.99 | 10.94 | -9.56 |
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal processing; and AI PrecisionPulse Neural Network for the analysis of biometric signals to detect cardiovascular anomalies and personalized health recommendations, as well as Health Gauge's solutions that capture vital signs, such as blood pressure, heart rate, and pulse wave velocity. It also engages in the research and development of health and wearable technologies; and sale of licenses and consulting services related to the company's technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. is headquartered in Victoria, Canada.
| Name | Title | Year Born |
|---|---|---|
| Mr. John Paul Duffy | President, CEO & Executive Chairman | 1966 |
| Mr. Terence Lee | Chief Financial Officer | 1988 |
| Mr. Esmat Naikyar | Chief Product Officer | NA |
| Mr. Erik Suokas | Chief Operating Officer | NA |
| Dr. Alan Rabinowitz FACC, FRCPC | Chief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships | NA |
| Ms. Andrea L. Ruth M.S. | Head of Quality, Clinical, & Regulatory | NA |
| Ms. Kendra Low BHK, M.B.A. | Company Secretary | 1980 |
| Mr. Terence Lee | Chief Financial Officer | 1989 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.